Abstract | PURPOSE: The purpose of this study was to quantify the extent of the anti-inflammatory effect of platelet-rich plasma (PRP) in a controlled in vitro environment. METHODS: Through the stimulation of human umbilical vein endothelial cells with inflammatory cytokines ( tumor necrosis factor α and interferon γ), cell adhesion molecule expression ( E-selectin, vascular cell adhesion molecule, and human leukocyte antigen DR) and PRP's anti-inflammatory effect can be measured. PRP was produced from 3 individuals using a single-spin (PRPLP) process. Treatment groups include negative (unstimulated) controls, positive (stimulated) controls, ketorolac tromethamine, methylprednisolone, PRP, ketorolac-PRP, and methylprednisolone-PRP. A fluorescence assay of the cellular inflammation markers was measured by the BioTek Synergy HT plate reader (BioTek Instruments, Winooski, VT) at 0, 1, 2, and 5 days. RESULTS: At days 2 and 5, methylprednisolone treatment showed a 2.1- to 5.8-fold reduction (P < .05) in inflammation markers over PRP. In addition, PRP and ketorolac showed a 1.4- to 2.5-fold reduction (P < .05) in cellular inflammation markers over the control. There was no statistically significant difference between ketorolac and PRP. CONCLUSIONS: CLINICAL RELEVANCE:
|
Authors | Augustus D Mazzocca, Mary Beth R McCarthy, Jessica Intravia, Knut Beitzel, John Apostolakos, Mark P Cote, James Bradley, Robert A Arciero |
Journal | Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association
(Arthroscopy)
Vol. 29
Issue 4
Pg. 675-83
(Apr 2013)
ISSN: 1526-3231 [Electronic] United States |
PMID | 23395471
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2013 Arthroscopy Association of North America. Published by Elsevier Inc. All rights reserved. |
Chemical References |
- Anti-Inflammatory Agents
- Methylprednisolone
- Ketorolac
|
Topics |
- Adult
- Anti-Inflammatory Agents
(pharmacology)
- Cells, Cultured
- Human Umbilical Vein Endothelial Cells
(drug effects, immunology)
- Humans
- Inflammation
- Ketorolac
(pharmacology)
- Male
- Methylprednisolone
(pharmacology)
- Platelet-Rich Plasma
(immunology)
- Young Adult
|